• Je něco špatně v tomto záznamu ?

A 12-month prospective, observational study of treatment regimen and quality of life associated with ADHD in central and eastern europe and eastern Asia

M. Goetz, CB. Yeh, I. Ondrejka, A. Akay, I. Herczeg, I. Dobrescu, BN. Kim, X. Jin, AW. Riley, F. Martényi, G. Harrison, T. Treuer,

. 2012 ; 16 (1) : 44-59.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12024477
E-zdroje Online Plný text

NLK SAGE Publications Journals od 1999-01-01 do 2015-12-31
SAGE Journals od 2012-01-01 do 2012-05-31

Odkazy

PubMed 20858785
DOI 10.1177/1087054710381480
Knihovny.cz E-zdroje

OBJECTIVES: This prospective, observational, non-randomized study aimed to describe the relationship between treatment regimen prescribed and the quality of life (QoL) of ADHD patients in countries of Central and Eastern Europe (CEE) and Eastern Asia over 12 months. METHODS: 977 Male and female patients aged 6-17 years seeking treatment for symptoms of ADHD were assessed using the Child and Adolescent Symptom Inventory-4 Parent Checklists, and the Clinical Global Impressions-ADHD-Severity scale. QoL was assessed using the Child Health and Illness Profile-Child Edition parent report form. Patients were grouped according to whether they were prescribed psycho- and/or pharmacotherapy (treatment) or not (no/'other' treatment). RESULTS: No statistically significant differences were observed between cohorts (treatment vs. no/'other' treatment) in terms of change in QoL, although there was improvement over 12 months, with a greater improvement experienced by patients in the treatment cohort in both study regions (CEE and Eastern Asia). Psychoeducation/counselling and methylphenidate were the predominant ADHD treatments prescribed. CONCLUSIONS: Although both treatment and no/'other' treatment cohorts showed improvements in mean QoL over 12 months, the difference was small and not statistically significant. A major limitation was the higher than anticipated number of patients switching treatments, predominantly from the no/'other' treatment cohort.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12024477
003      
CZ-PrNML
005      
20150826102308.0
007      
ta
008      
120815s2012 xxu d f 000 0eng||
009      
AR
024    7_
$a 10.1177/1087054710381480 $2 doi
035    __
$a (PubMed)20858785
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Goetz, Michal, $u Charles University, Second Medical Faculty, Prague, Czech Republic $d 1972- $7 mzk2004228210
245    12
$a A 12-month prospective, observational study of treatment regimen and quality of life associated with ADHD in central and eastern europe and eastern Asia / $c M. Goetz, CB. Yeh, I. Ondrejka, A. Akay, I. Herczeg, I. Dobrescu, BN. Kim, X. Jin, AW. Riley, F. Martényi, G. Harrison, T. Treuer,
520    9_
$a OBJECTIVES: This prospective, observational, non-randomized study aimed to describe the relationship between treatment regimen prescribed and the quality of life (QoL) of ADHD patients in countries of Central and Eastern Europe (CEE) and Eastern Asia over 12 months. METHODS: 977 Male and female patients aged 6-17 years seeking treatment for symptoms of ADHD were assessed using the Child and Adolescent Symptom Inventory-4 Parent Checklists, and the Clinical Global Impressions-ADHD-Severity scale. QoL was assessed using the Child Health and Illness Profile-Child Edition parent report form. Patients were grouped according to whether they were prescribed psycho- and/or pharmacotherapy (treatment) or not (no/'other' treatment). RESULTS: No statistically significant differences were observed between cohorts (treatment vs. no/'other' treatment) in terms of change in QoL, although there was improvement over 12 months, with a greater improvement experienced by patients in the treatment cohort in both study regions (CEE and Eastern Asia). Psychoeducation/counselling and methylphenidate were the predominant ADHD treatments prescribed. CONCLUSIONS: Although both treatment and no/'other' treatment cohorts showed improvements in mean QoL over 12 months, the difference was small and not statistically significant. A major limitation was the higher than anticipated number of patients switching treatments, predominantly from the no/'other' treatment cohort.
650    _2
$a mladiství $7 D000293
650    _2
$a hyperkinetická porucha $x farmakoterapie $x psychologie $x terapie $7 D001289
650    _2
$a stimulanty centrálního nervového systému $x terapeutické užití $7 D000697
650    _2
$a dítě $7 D002648
650    _2
$a poradenství $7 D003376
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a methylfenidát $x terapeutické užití $7 D008774
650    _2
$a prospektivní studie $7 D011446
650    _2
$a kvalita života $x psychologie $7 D011788
650    _2
$a výsledek terapie $7 D016896
651    _2
$a východní Evropa $7 D005061
651    _2
$a Dálný východ $7 D005202
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Yeh, Chin-Bin $u Tri Service General Hospital, Taipei, Taiwan
700    1_
$a Ondrejka, Igor $7 xx0105387 $u Comenius University, Martin, Slovak Republic
700    1_
$a Akay, Aynur $u Dokuz Eylül University School of Medicine, Izmir, Turkey $7 gn_A_00002836
700    1_
$a Herczeg, Ilona $u Heim Pal Hospital, Budapest, Hungary
700    1_
$a Dobrescu, Iuliana $u UMF “Carol Davila”, “Al. Obregia” Psychiatry Hospital, Bucharest, Romania
700    1_
$a Kim, Boong Nyun $u Seoul National University Hospital, Seoul, Korea
700    1_
$a Jin, Xingming $u Shanghai Jiaotong University, Shanghai, P.R. China
700    1_
$a Riley, Anne W. $u Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
700    1_
$a Martényi, Ferenc $u Lilly Research Laboratories, Indianapolis, IN, USA
700    1_
$a Harrison, Gavan $u Intercontinental Information Sciences, Eli Lilly Pty Ltd, Sydney, NSW, Australia
700    1_
$a Treuer, Tamás $u Eli Lilly Area Medical Center, Vienna, Austria
773    0_
$w MED00180281 $t Journal of attention disorders $x 1557-1246 $g Roč. 16, č. 1 (2012), s. 44-59
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20858785 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120815 $b ABA008
991    __
$a 20150826102422 $b ABA008
999    __
$a ok $b bmc $g 946625 $s 781805
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 16 $c 1 $d 44-59 $i 1557-1246 $m Journal of attention disorders $n J Atten Disord $x MED00180281
LZP    __
$b NLK118 $a Pubmed-20120815/12/02

Najít záznam

Citační ukazatele

Možnosti archivace